Skip to main navigation Skip to search Skip to main content

Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

  • National Registry of Rare Kidney Diseases
  • University College London
  • The UK Kidney Association
  • UK Renal Registry
  • St George's University of London
  • St George's University Hospitals NHS Foundation Trust
  • University of Leicester
  • University of Exeter
  • Royal Devon University Healthcare NHS Foundation Trust
  • University of Bristol
  • Bristol Medical School
  • University of Manchester
  • Good Hope Hospital
  • Guy's and St Thomas NHS Foundation Trust
  • Cardiff Metropolitan University
  • University of Nottingham
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • University of Cambridge
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Newcastle University
  • Birmingham Women's Hospital NHS Trust
  • Royal Free London NHS Foundation Trust
  • University Hospitals Birmingham NHS Foundation Trust
  • University of Sheffield
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Northern Care Alliance NHS Foundation Trust
  • South Tyneside and Sunderland NHS Foundation Trust
  • Royal Brompton Hospital
  • Edinburgh Napier University
  • Gt. Ormond St. Hospital for Children
  • University College Cork
  • Pfizer
  • London School Of Hygiene and Tropical Medicine
  • King's College London

Research output: Contribution to journal › Article › peer-review

19 Downloads (Pure)

Abstract

INTRODUCTION: The National Registry of Rare Kidney Diseases (RaDaR) collects data from people living with rare kidney diseases across the UK, and is the world's largest, rare kidney disease registry. We present the clinical demographics and renal function of 25,880 prevalent patients and sought evidence of bias in recruitment to RaDaR.

METHODS: RaDaR is linked with the UK Renal Registry (UKRR, with which all UK patients receiving kidney replacement therapy [KRT] are registered). We assessed ethnicity and socioeconomic status in the following: (i) prevalent RaDaR patients receiving KRT compared with patients with eligible rare disease diagnoses receiving KRT in the UKRR, (ii) patients recruited to RaDaR compared with all eligible unrecruited patients at 2 renal centers, and (iii) the age-stratified ethnicity distribution of RaDaR patients with autosomal dominant polycystic kidney disease (ADPKD) was compared to that of the English census.

RESULTS: We found evidence of disparities in ethnicity and social deprivation in recruitment to RaDaR; however, these were not consistent across comparisons. Compared with either adults recruited to RaDaR or the English population, children recruited to RaDaR were more likely to be of Asian ethnicity (17.3% vs. 7.5%, P-value < 0.0001) and live in more socially deprived areas (30.3% vs. 17.3% in the most deprived Index of Multiple Deprivation (IMD) quintile, P-value < 0.0001).

CONCLUSION: We observed no evidence of systematic biases in recruitment of patients into RaDaR; however, the data provide empirical evidence of negative economic and social consequences (across all ethnicities) experienced by families with children affected by rare kidney diseases.

Original languageEnglish
Pages (from-to)2067-2083
Number of pages17
JournalKidney International Reports
Volume9
Issue number7
Early online date9 May 2024
DOIs
Publication statusPublished - Jul 2024

Bibliographical note

Copyright © 2024 International Society of Nephrology. Published by Elsevier Inc. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).

Data Access Statement

The RaDaR database is hosted by the UK Renal Registry and its metadata are available via https://rarerenal.org.
Individual-level data are not available for export. Proposals to perform analyses using the data for academic, audit or
commercial purposes can be made to the RaDaR Operations Group via https://rarerenal.org

Funding

The authors thank all RaDaR participants, their family members, and the UK Renal Registry staff. RaDaR has received support from the UK Kidney Association, the UK Medical Research Council, Kidney Research UK, Kidney Care UK, and the Polycystic Kidney Disease Charity. This work was partly supported by Pfizer Inc.

Keywords

  • ethnicity
  • RaDaR
  • rare kidney disease registry
  • rare kidney diseases
  • social deprivation

Fingerprint

Dive into the research topics of 'Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort'. Together they form a unique fingerprint.

Cite this